Technical Analysis for MNTA - Momenta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 11.79 0.26% 0.03
MNTA closed up 2.62 percent on Thursday, January 17, 2019, on 73 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical MNTA trend table...

Date Alert Name Type % Chg
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.26%
Jan 17 Stochastic Reached Overbought Strength 0.26%
Jan 17 Weak + Overbought Other 0.26%
Jan 17 Inside Day Range Contraction 0.26%
Jan 17 Above Upper BB Strength 0.26%
Jan 17 Overbought Stochastic Strength 0.26%
Jan 17 Up 3 Days in a Row Strength 0.26%
Jan 17 Upper Bollinger Band Touch Strength 0.26%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.88%
Jan 16 BB Squeeze Ended Range Expansion 2.88%

Older signals for MNTA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Momenta Pharmaceuticals, Inc., a biotechnology company, engages in the structural characterization, process engineering, and biologic systems analysis of complex molecules. Its complex molecules include polysaccharides, polypeptides, and proteins and antibodies. The company's complex generics programs comprise Enoxaparin sodium injection, a generic version of Lovenox that is used for the prevention and treatment of deep vein thrombosis, and to support the treatment of acute coronary syndromes; and M356, a generic version of Copaxone, which is a glatiramer acetate injection indicated for the reduction of the frequency of relapses in patients with relapsing-remitting multiple sclerosis. Its biosimilars programs include M923, a biosimilar for autoimmune and inflammatory diseases; M834 for autoimmune and inflammatory diseases; and M511, a monoclonal antibody for oncology. The company's novel products comprise M402, a novel heparan sulfate mimetic that binds to various growth factors, adhesion molecules, and chemokines to inhibit tumor angiogenesis, progression, and metastasis; and the sialylation technology, which is a discovery program that is intended to modify immunoglobulin G antibodies in intravenous immunoglobulin, a drug to treat autoimmune and inflammatory diseases. It has collaboration agreements with Sandoz AG; Baxter International, Inc.; Baxter Healthcare Corporation; and Baxter Healthcare SA. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.
Is MNTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 32.2
52 Week Low 9.55
Average Volume 851,673
200-Day Moving Average 20.246
50-Day Moving Average 11.9067
20-Day Moving Average 10.9435
10-Day Moving Average 11.022
Average True Range 0.8498
ADX 15.92
+DI 17.8002
-DI 16.9476
Chandelier Exit (Long, 3 ATRs ) 9.6406
Chandelier Exit (Short, 3 ATRs ) 12.099400000000001
Upper Bollinger Band 11.6761
Lower Bollinger Band 10.2109
Percent B (%b) 1.06
BandWidth 13.38877
MACD Line -0.2148
MACD Signal Line -0.3941
MACD Histogram 0.1793
Fundamentals Value
Market Cap 867.81 Million
Num Shares 73.8 Million
EPS -0.64
Price-to-Earnings (P/E) Ratio -18.38
Price-to-Sales 9.20
Price-to-Book 2.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.56
Resistance 3 (R3) 12.47 12.12 12.42
Resistance 2 (R2) 12.12 11.92 12.16 12.38
Resistance 1 (R1) 11.94 11.79 12.03 12.03 12.33
Pivot Point 11.59 11.59 11.64 11.63 11.59
Support 1 (S1) 11.41 11.39 11.50 11.50 11.19
Support 2 (S2) 11.06 11.26 11.10 11.14
Support 3 (S3) 10.88 11.06 11.10
Support 4 (S4) 10.97